Trial intelligence / Profile preview

PVAG-14 in intermediate-stage Hodgkin's lymphoma

2007-003467-48Phase 2Completed

Sponsor: University of Cologne
Start: Oct 2007
Modality: DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
Countries: 1

Overview

Phase 2, randomised trial of prednisone, vinblastine, doxorubicin and gemcitabine in Hodgkin lymphoma (HL), sponsored by University of Cologne. Primary endpoint: Incidence of hematological toxicity grade III/IV. Started Oct 2007; status: completed.

Drugs

prednisonevinblastinedoxorubicingemcitabine

Conditions

Hodgkin lymphoma (HL)

Beyond the preview

Go deeper on 2007-003467-48.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-003467-48.